Chemotherapy plus single/double immunotherapy in the treatment of non-oncogene addicted advanced non-small cell lung cancer: where do we stand and where are we going?-Reference-Cited by-同舟云学术

Chemotherapy plus single/double immunotherapy in the treatment of non-oncogene addicted advanced non-small cell lung cancer: where do we stand and where are we going?

Published:2022-01-20 Issue:2 Volume:22 Page:183-189
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Rocco Danilo¹,Della Gravara Luigi²,Franzese Nicola³,Maione Paolo⁴,Gridelli Cesare⁴

Affiliation:

1. Department of Pulmonary Oncology, AORN dei Colli Monaldi, Naples, Italy

2. Department of Experimental Medicine, Università degli studi della Campania ‘Luigi Vanvitelli’, Naples, Italy

3. Department of Pneumology, Università degli studi della Campania ‘Luigi Vanvitelli’, Naples, Italy

4. Division of Medical Oncology, ‘S.G. Moscati’ Hospital, Avellino, Italy

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2022.2026772

Reference58 articles.

1. FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy

2. FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond

3. U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non–Small Cell Lung Cancer

4. A new era of treating advanced lung cancer is upon us

5. Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade;Clinical Cancer Research;2023-12-07

2. Advancement of anti‐LAG‐3 in cancer therapy;The FASEB Journal;2023-10-17

3. Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer;Pharmaceuticals;2023-07-22

4. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor;Open Life Sciences;2023-01-01

5. Immune Checkpoint Inhibitors in Cancer Therapy;Current Oncology;2022-04-24